- Live market news
- Stocks
- SYRE
Spyre Therapeutics Inc.
SYREStockUSA
Key figures
- Previous close
- 99.04
- Open
- 98.38
- Day range
- 93.83 – 98.75
- 52-week range
- —
- Volume
- 1.16M
Latest news on SYREranked by Oyticker for market impact
- 45Impact
Spyre Therapeutics prices $350M equity offering at $85/share
Clinical-stage biotech Spyre Therapeutics priced a $350M public offering of 4.1M shares at $85/share, with underwriters granted a 30-day option for an additional $52.5M tranche. Closing expected October 7, 2026.
SYREBiotechnologyHealthcare - 35Impact
Spyre Therapeutics announces underwritten public offering of common stock
Clinical-stage biotech Spyre Therapeutics (SYRE) has commenced an underwritten public offering of common stock with a 30-day greenshoe option for underwriters to purchase an additional 15% of shares offered. Offering size, pricing and completion remain subject to market conditions.
SYREBiotechnologyHealthcare
In detailthe same figures as in Oyticker Charts
Performance
Ranges & volume
- Open
- 98.38
- Prev. close
- 99.04
Risk · 1 year
Seasonality
What SYRE filed
- 3 Nov 2026
- 3 Nov 2026
- 7 Oct 2026
- 8 Sept 2026
Other event
- 25 Aug 2026
Other event
- 4 Aug 2026
- 4 Aug 2026
- 15 Jun 2026
Other event
- 1 Jun 2026
- 29 May 2026
Shareholder vote results
From SEC EDGAR, the public record of what US-listed companies file. Each document opens on sec.gov.
Oyticker provides market information and analysis for educational purposes. It is not investment advice: you remain responsible for your own decisions.